Cambrian is a drug research and distribution company. With a mission to develop curative therapies for age-related diseases, Cambrian is partnering with clinical development researchers to help treat cellular dysfunction and tissue degeneration. Some programs included in the Cambrian pipeline include Telos Biotech, Tornado Therapeutics, and Amplifier Therapeutics. Cambrian was founded by Christian Angermayer, James Peyer, and Sebastian Brunemeier in 2019 and is headquartered in New York, New York.

Register for Details

For more details on financing and valuation for Cambrian, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Cambrian

Forge green plus iconForge green minus icon

What is Cambrian's IPO price?

The IPO price for Cambrian will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Cambrian?

Cambrian is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Cambrian shares pre-IPO?

If you own Cambrian pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Cambrian a publicly traded company?

Cambrian is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Cambrian's funding to date?

Cambrian has raised $149.86MM to date.
Forge green plus iconForge green minus icon

When was Cambrian founded?

Cambrian was founded in 2019.

Who are Cambrian's major investors?

Alumni Ventures
Anthos Capital
FJ Labs
Subversive Capital
Galaxy Digital
NJF Capital
Korify Capitals
Calm Ventures
TA Ventures
Verve Ventures
Longevity Vision Fund
DEFTA Partners
Moore Capital Management

Cambrian Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
10/26/2021 Series C $100.78MM raised $XXX.XX $XXX.XX
2/9/2021 Series B $28.83MM raised $XXX.XX $XXX.XX
11/15/2019 Series A $15.5MM raised $XXX.XX $XXX.XX
10/29/2019 Series Seed $4.75MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.